F. Greco
Molecular Biology · 2009
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 7 citations into it
Whom F. Greco trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from F. Greco's perspective
Ordered by how strongly the researchers F. Greco trusts endorse each paper. Same corpus, a different order for every researcher.
- Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)
- Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
- Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy (Nature)
- Effect of pegylation on pharmaceuticals (Nature reviews. Drug discovery)
- Chemistry for peptide and protein PEGylation. (Advanced Drug Delivery Reviews)
- The dawning era of polymer therapeutics (Nature reviews. Drug discovery)
- Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. (Molecular Biology of the Cell)
- Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR (Proceedings of the National Academy of Sciences of the United States of America)
- Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. (New England Journal of Medicine)
- Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. (The Lancet)